dystrophin Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of dystrophin monoclonal antibodies, essential tools for researchers studying muscular dystrophies and related disorders. dystrophin Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Dystrophin plays a vital role in maintaining the structural integrity of muscle cells by linking the cytoskeleton to the extracellular matrix. Mutations in the dystrophin gene can lead to severe muscle degeneration, as seen in conditions like Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD). Understanding dystrophin function and regulation is crucial for developing therapeutic strategies for muscle-related diseases. Researchers worldwide rely on dystrophin monoclonal antibodies to investigate muscle cell structure and function. Advanced research techniques using dystrophin monoclonal antibodies help identify potential therapeutic targets. Ongoing studies with dystrophin monoclonal antibodies continue to reveal new insights into muscle disorders. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to muscular dystrophy research and potential treatment development.